Pinnacle Associates’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$283K Sell
5,201
-394
-7% -$19.2K ﹤0.01% 834
2026
Q1
$240K Sell
5,595
-1,174
-17% -$50.5K ﹤0.01% 866
2025
Q4
$297K Buy
+6,769
New +$280K ﹤0.01% 788

Other funds holding EXEL

Pinnacle Associates's EXEL Position: Q2 2026 in Review

Pinnacle Associates reduced its Exelixis (EXEL) stake by 7% in Q2 2026, selling an estimated $19.2K and leaving 5,201 shares worth $283K. The position accounts for ﹤0.01% of the portfolio, ranked #834.

Pinnacle Associates first reported a position in EXEL in Q4 2025 and has held it in 3 quarters since. The position peaked at $297K in Q4 2025. 758 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • Pinnacle Associates held 5,201 shares of Exelixis worth $283K as of Q2 2026.
  • Pinnacle Associates sold 394 Exelixis shares in Q2 2026, an estimated $19.2K.
  • Exelixis made up ﹤0.01% of Pinnacle Associates's portfolio in Q2 2026, its #834 holding.
  • Pinnacle Associates first reported a position in Exelixis in Q4 2025 and has held it in 3 quarters since.
  • Pinnacle Associates's Exelixis position peaked at $297K in Q4 2025.
  • 758 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Pinnacle Associates's 13F filing for Q2 2026, filed 3 Aug 2026.